Previous close | 102.98 |
Open | 101.68 |
Bid | 99.24 x 1200 |
Ask | 99.45 x 1000 |
Day's range | 98.24 - 102.26 |
52-week range | 80.90 - 116.04 |
Volume | |
Avg. volume | 2,267,614 |
Market cap | 24.091B |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | 39.25 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.00 (1.96%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2024 revenues of $54.9 billion, an increase of 9% from the third quarter of fiscal year 2023. Third quarter GAAP operating earnings were $367 million and GAAP diluted earnings per share (EPS) were $1.05, which included a non-cash, pre-tax goodwill impairment of $90 million related to the Global Medical Products and Distribution (GMPD) segment as a result of the reallocation of goodwill related to the reporting structure update.
Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its fiscal 2024 non-GAAP diluted EPS guidance of $7.20 to $7.35. Despite the nonrenewal of the OptumRx contracts, the company also reiterated both its Pharmaceutical and Specialty Solutions long-term segment profit CAGR target of 4% to 6% and its consolidated non-GAAP EPS CAGR target of 12% to 14% for fiscal yea
Today, Cardinal Health (NYSE: CAH) announced that construction has begun for a new 350,000 square-foot logistics center in Columbus, Ohio, that will serve as a centralized replenishment center for the distribution of over-the-counter consumer health products in support of its core pharmaceutical business.